XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting - Schedule of Segment Revenue and Operating Income (Details)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Segment Reporting [Abstract]          
Number of operating segments | segment       2  
Segment Reporting Information [Line Items]          
Revenues   $ 674.1 $ 620.6 $ 2,007.9 $ 1,832.2
Adjusted EBITDA   105.5 96.2 295.8 259.4
Reconciliation of Adjusted EBITDA:          
Income before income taxes   32.8 13.4 82.3 77.1
Net income attributable to non-controlling interests   (34.6) (30.6) (99.5) (94.9)
Interest expense, net   49.8 60.7 144.3 173.9
Depreciation and amortization   28.9 29.8 87.0 85.2
Equity-based compensation expense   4.4 5.0 13.2 13.0
Transaction, integration and acquisition costs   13.0 13.1 38.8 28.4
Net loss on disposals, consolidations and deconsolidations   5.8 2.2 7.5 3.2
Litigation settlements and regulatory change impact   4.2 1.5 13.9 (27.6)
Undesignated derivative activity   0.0 0.0 0.6 0.0
Other   1.2 1.1 7.7 1.1
Adjusted EBITDA   105.5 96.2 295.8 259.4
Transaction and integration costs   12.8 12.5 37.3 27.8
Start-up costs   0.2 0.6 1.5 0.6
Other litigation costs   0.6 1.5 1.4 5.2
(Loss) gain on litigation settlement $ 32.8 (3.6) 0.0 (8.1) 32.8
Additional interest expense for Florida LOP regulation change       4.4  
Operating Segments | Surgical Facility Services          
Segment Reporting Information [Line Items]          
Revenues   657.3 603.9 1,956.5 1,780.6
Adjusted EBITDA   138.6 110.2 384.1 319.9
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   138.6 110.2 384.1 319.9
Operating Segments | Ancillary Services          
Segment Reporting Information [Line Items]          
Revenues   16.8 16.7 51.4 51.6
Adjusted EBITDA   (1.2) (1.5) (2.7) (2.2)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   (1.2) (1.5) (2.7) (2.2)
All other          
Segment Reporting Information [Line Items]          
Adjusted EBITDA   (31.9) (12.5) (85.6) (58.3)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   $ (31.9) $ (12.5) $ (85.6) $ (58.3)